AU2001261023A1 - Use of an ampa receptor potentiator for the treatment of obesity - Google Patents
Use of an ampa receptor potentiator for the treatment of obesityInfo
- Publication number
- AU2001261023A1 AU2001261023A1 AU2001261023A AU6102301A AU2001261023A1 AU 2001261023 A1 AU2001261023 A1 AU 2001261023A1 AU 2001261023 A AU2001261023 A AU 2001261023A AU 6102301 A AU6102301 A AU 6102301A AU 2001261023 A1 AU2001261023 A1 AU 2001261023A1
- Authority
- AU
- Australia
- Prior art keywords
- obesity
- treatment
- ampa receptor
- receptor potentiator
- potentiator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20666200P | 2000-05-24 | 2000-05-24 | |
US60/206,662 | 2000-05-24 | ||
PCT/US2001/011769 WO2001089510A2 (en) | 2000-05-24 | 2001-05-11 | Use of an ampa receptor potentiator for the treatment of obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001261023A1 true AU2001261023A1 (en) | 2001-12-03 |
Family
ID=22767386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001261023A Abandoned AU2001261023A1 (en) | 2000-05-24 | 2001-05-11 | Use of an ampa receptor potentiator for the treatment of obesity |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001261023A1 (en) |
WO (1) | WO2001089510A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002089848A2 (en) * | 2001-05-04 | 2002-11-14 | Eli Lilly And Company | Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes |
WO2003032974A2 (en) * | 2001-10-12 | 2003-04-24 | Eli Lilly And Company | Use of sulfonamide derivatives as pharmaceuticals compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9702194D0 (en) * | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
PE20000944A1 (en) * | 1998-07-31 | 2000-09-20 | Lilly Co Eli | SULFONAMIDE DERIVATIVES |
WO2000006537A1 (en) * | 1998-07-31 | 2000-02-10 | Eli Lilly And Company | N-substituted sulfonamide derivatives |
-
2001
- 2001-05-11 AU AU2001261023A patent/AU2001261023A1/en not_active Abandoned
- 2001-05-11 WO PCT/US2001/011769 patent/WO2001089510A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001089510A3 (en) | 2002-07-25 |
WO2001089510A2 (en) | 2001-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2935200A (en) | Compounds for the treatment of obesity | |
HK1047284A1 (en) | 2-amino-benzoxazinone derivatives for the treatment of obesity | |
AU2001243462A1 (en) | Improved thoraco-lumbo-sacral orthosis | |
AU2003299791A1 (en) | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity | |
AU2002348226A1 (en) | Invasive therapeutic probe | |
AU2002222853A1 (en) | Therapeutic compounds | |
AU1260401A (en) | Thumb splint | |
AU2002341963A1 (en) | Flushable commode liner | |
AU2001253070A1 (en) | Isoflavones for treatment of obesity | |
AU2003290059A1 (en) | Use of cd137 antagonists for the treatment of tumors | |
AU2001272974A1 (en) | Human receptors | |
AU2002353739A1 (en) | Therapeutic compounds | |
AU2001264920A1 (en) | Therapeutic uses of il-1 receptor antagonist | |
AU2002236781A1 (en) | Treatment for snoring | |
AU2003236649A1 (en) | Egf receptor antagonists in the treatment of gastric cancer | |
AU2001261023A1 (en) | Use of an ampa receptor potentiator for the treatment of obesity | |
AU2002355919A1 (en) | Massage apparatus for bowels | |
AU2003264297A1 (en) | Use of vanilloid receptor antagonists for the treatment of pain | |
AU2002336782A1 (en) | Penis vibrator | |
AU2000272704A1 (en) | Use of compounds for the treatment of obesity | |
AU2002367305A1 (en) | Foot orthosis | |
AU2002315522A1 (en) | Receptor agonists useful for the treatment of pain | |
AU2003300867A1 (en) | Uses of the snorf207 receptor | |
AU5621501A (en) | Regulation of human ephrin-like receptor | |
AU2002309243A1 (en) | Heterocyclic compounds for therapeutic use |